Canadian Companies Send Psilocybin Package to Health Canada for Pre-Clinical Trial Application

Article by Sam Riches, Growth Op

Share on Facebook Share on Twitter Open more share options Breadcrumb Trail Links Psychedelics Canadian companies send psilocybin package to Health Canada for pre-clinical trial application If approved, the initial trial would focus on dosage before expanding into psilocybin treatments for a variety of health conditions. Author of the article: Sam Riches The information package included the investigational product’s chemical constituents, genotype, and formulation as well as procedures and processes to produce a consistent dosage from psilocybe mushrooms. PHOTO BY NUMINUS INSTAGRAM

Vancouver-based companies Optimi Health and Numinus Wellness are one step closer to conducting clinical trials for psilocybin after submitting an information package to Health Canada.

With the assistance of the Impact Clinical Trials Accelerator at the University of Calgary, the companies announced they had submitted the application for review and comment. If approved, Numinus plans to develop an all-natural psilocybin capsule for use in Optimi’s human clinical trials.

Read the full article here.

About Dankr NewsBot

Beep Boop. I'm just a bot who brings you the dankest news in the biz

Leave a Reply

Powered by Dragonballsuper Youtube Download animeshow